The change of tack follows a strategic review by new chief executive Tom Oakley, who believes Cadran can become the go-to method of securely sharing patient information by mobile phone or tablet.
Research presented in the British Medical Journal reveals that 97% of doctors discuss patients via WhatsApp, which presents security and GDPR compliance issues.
Cadran not only provides an ultra-secure method of sharing information, it is the only communication tool to be CE marked as a medical device, Feedback pointed out. This means it has been through a rigorous EU approval process.
CEO Oakley said: "An exciting opportunity has arisen from the first phase of our strategic review.
“We believe that Cadran's innovative features, such as the ability to view clinical grade medical images flexibly on mobile and personal devices, allow it to be repositioned to meet the needs of an emerging medical communications market, particularly in medical imaging.
"There is huge potential to improve the efficiencies and lives of our doctors and patients alike, through more flexible, secure and accurate tools utilising the highest standards in global mobile communications. We are now working swiftly to develop this new offering and make it available for the many clinicians eager to use it, both within the NHS and internationally."
In the same announcement, the specialist medical imaging group said revenues for the year ended May were £563,000, up 23%.